We are live on
!
Find out more
EWM
Essex Woodlands Management Portfolio holdings
AUM
$254M
1-Year Est. Return
4.59%
This Fund
S&P 500
This Quarter
Est. Return
+40.81%
1 Year Est. Return
+4.59%
3 Year Est. Return
+54.96%
5 Year Est. Return
+25.37%
10 Year Est. Return
+254.56%
AUM
$554M
AUM Growth
+$49.9M
(+9.9%)
Cap. Flow
-$66.8M
Cap. Flow
% of AUM
-12.05%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
1
Reduced
2
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ENTL
Entellus Medical, Inc. Common Stock
ENTL
|
+$25 |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ABMD
Abiomed Inc
ABMD
|
+$66.4M |
| 2 |
ACUR
Acura Pharmaceuticals
ACUR
|
+$343K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 95.51% |
Similar funds
TSM
LI
LIA
IGM
WWM
MWM
LRIC
CIM
Essex Woodlands Management's Q2 2015 Portfolio in Review
As of Q2 2015, Essex Woodlands Management held 7 positions worth $554M, up 9.9% from $504M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Essex Woodlands Management withdrew a net $66.8M in Q2 2015, reducing 2 holdings. Its largest reduction was Abiomed Inc, cutting an estimated $66.4M.
By sector, the portfolio is most concentrated in Healthcare at 96% of assets, up from 95% a quarter earlier.
Against the trend, Essex Woodlands Management added an estimated $25 to Entellus Medical, Inc. Common Stock.
- Essex Woodlands Management added most to Entellus Medical, Inc. Common Stock in Q2 2015, an estimated $25 increase.
- Essex Woodlands Management's biggest Q2 2015 reduction was Abiomed Inc, cutting an estimated $66.4M.
- Essex Woodlands Management's ten largest holdings make up 100% of its $554M portfolio in Q2 2015.
- Essex Woodlands Management opened 0 new positions and closed 0 in Q2 2015.
- Essex Woodlands Management's portfolio value rose 9.9% quarter-over-quarter to $554M.
Based on Essex Woodlands Management's 13F filing for Q2 2015, filed 11 Aug 2015.